Common use of Payment Currency Clause in Contracts

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges.

Appears in 19 contracts

Sources: License Agreement (AVROBIO, Inc.), Exclusive License Agreement (Ocean Biomedical, Inc.), Exclusive License Agreement (Ocean Biomedical, Inc.)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working business day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges.

Appears in 6 contracts

Sources: Intellectual Property License Agreement (Immune Therapeutics, Inc.), License Agreement (Gatc Health Corp), License Agreement

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection or other charges.

Appears in 6 contracts

Sources: License Agreement (Genocea Biosciences, Inc.), License Agreement, License Agreement (Genocea Biosciences, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will shall be made as of the last working day of the applicable Calendar Quarter at the applicable conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the or, solely with respect to Sublicenses, at another commercially reasonable, publicly available, applicable Calendar Quarter. Such payments will conversion rate as may be without deduction of exchange, collection or other chargesprovided in a Sublicense.

Appears in 5 contracts

Sources: License Agreement (BioNTech SE), License Agreement, License Agreement (Neon Therapeutics, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. DollarsUnited States dollars. Conversion of foreign currency to U.S. Dollars will dollars shall be made at the conversion rate existing in the United States (as reported in the The Wall Street JournalJournal U.S. Internet edition at ▇▇▇.▇▇▇.▇▇▇) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection collection, or other charges.

Appears in 3 contracts

Sources: License Agreement (Aileron Therapeutics Inc), License Agreement (Aileron Therapeutics Inc), License Agreement (Aileron Therapeutics Inc)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. DollarsDollars unless agreed otherwise in writing. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar QuarterQuarter or payment due date. Such payments will shall be without deduction of exchange, collection or other charges.

Appears in 3 contracts

Sources: License Agreement (Artemis Therapeutics, Inc.), License Agreement (New York Global Innovations Inc.), License Agreement (New York Global Innovations Inc.)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection collection, or other charges.

Appears in 3 contracts

Sources: License Agreement, License Agreement (Kronos Bio, Inc.), License Agreement (Kronos Bio, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. DollarsUnited States dollars. Conversion of foreign currency to U.S. Dollars will dollars shall be made at the conversion rate existing in the United States (as reported in the The Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection collection, or other charges.

Appears in 2 contracts

Sources: License Agreement (Raindance Technologies Inc), License Agreement (Raindance Technologies Inc)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street JournalJournal U.S. Internet edition at ▇▇▇.▇▇▇.▇▇▇) on the last working day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges.

Appears in 2 contracts

Sources: License Agreement (10x Genomics, Inc.), License Agreement (10x Genomics, Inc.)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments due will be paid without deduction of exchange, collection or other charges.

Appears in 2 contracts

Sources: License Agreement (ReWalk Robotics Ltd.), License Agreement (ReWalk Robotics Ltd.)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quartercalendar quarter. Such payments will be without deduction of exchange, collection or other charges.

Appears in 2 contracts

Sources: License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. DollarsDollars unless agreed otherwise in writing. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) Journal on the last working day of the applicable Calendar Quartercalendar month. Such payments will shall be without deduction of exchange, collection or other charges.

Appears in 1 contract

Sources: Exclusive License Agreement (Sg Blocks, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the The Wall Street JournalJournal ) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection collection, or other charges.

Appears in 1 contract

Sources: License Agreement (La Jolla Pharmaceutical Co)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) Journa on the last working business day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges.

Appears in 1 contract

Sources: Exclusive License Agreement (Hoth Therapeutics, Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection collection, or other charges.

Appears in 1 contract

Sources: License Agreement (Tetralogic Pharmaceuticals Corp)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter[***]. Such payments will be without deduction of exchange, collection or other charges.

Appears in 1 contract

Sources: Exclusive License Agreement (Horizon Therapeutics Public LTD Co)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the The Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection collection, or other charges.

Appears in 1 contract

Sources: License Agreement (Tetraphase Pharmaceuticals Inc)

Payment Currency. All payments due under this Agreement will be paid in U.S. Dollars. Conversion of foreign currency to U.S. Dollars will be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) on the last working day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges. Notwithstanding the foregoing, a reasonable and customary currency conversion methodology as is set forth in a Sublicense agreement shall be the method used for currency conversion of amounts due in relation to such Sublicense agreement.

Appears in 1 contract

Sources: License Agreement (Beam Therapeutics Inc.)

Payment Currency. All payments due under this Agreement will shall be paid payable in U.S. DollarsDollars unless agreed otherwise in writing. Conversion of foreign currency to U.S. Dollars will shall be made at the conversion rate existing in the United States (as reported in the Wall Street Journal) Journal on the last working day of the applicable Calendar Quarter. Such payments will shall be without deduction of exchange, collection or other charges.

Appears in 1 contract

Sources: Research and License Agreement (Immix Biopharma, Inc.)